| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
About tyrosine kinase inhibitors (TKIs) in prostate cancer: where do we go from here?
|
Aragon-Ching, J.B.
|
|
|
21 |
1 |
p. 183-184
|
artikel
|
| 2 |
Acute aortic dissection during sorafenib-containing therapy
|
Serrano, C.
|
|
|
21 |
1 |
p. 181-182
|
artikel
|
| 3 |
Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma
|
Edeline, J.
|
|
|
21 |
1 |
p. 186-187
|
artikel
|
| 4 |
A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction
|
Moehler, M.
|
|
|
21 |
1 |
p. 71-77
|
artikel
|
| 5 |
A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX30 and chronomodulated XELOX30 as first-line therapy in patients with advanced colorectal cancer
|
Qvortrup, C.
|
|
|
21 |
1 |
p. 87-91
|
artikel
|
| 6 |
Call for abstracts!
|
|
|
|
21 |
1 |
p. vi-vii
|
artikel
|
| 7 |
Capecitabine after gastrectomy for advanced gastric cancer: have we got the patient right?
|
Fornaro, L.
|
|
|
21 |
1 |
p. 181
|
artikel
|
| 8 |
Circulating tumor cells and bone metastases as detected by FDG–PET/CT in patients with metastatic breast cancer
|
De Giorgi, U.
|
|
|
21 |
1 |
p. 33-39
|
artikel
|
| 9 |
Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck cancers
|
Gokhale, A.S.
|
|
|
21 |
1 |
p. 145-151
|
artikel
|
| 10 |
Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts
|
Larbouret, C.
|
|
|
21 |
1 |
p. 98-103
|
artikel
|
| 11 |
Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group
|
Sperr, W.R.
|
|
|
21 |
1 |
p. 114-119
|
artikel
|
| 12 |
Cultural competence in oncology: where do we stand?
|
Surbone, A.
|
|
|
21 |
1 |
p. 3-5
|
artikel
|
| 13 |
Dismissing links between HPV and aggressive tongue cancer in young patients
|
Salem, A.
|
|
|
21 |
1 |
p. 13-17
|
artikel
|
| 14 |
Editorial board
|
|
|
|
21 |
1 |
p. ii-v
|
artikel
|
| 15 |
Effects of antioxidant supplements on cancer prevention: meta-analysis of randomized controlled trials
|
Myung, S.-K.
|
|
|
21 |
1 |
p. 166-179
|
artikel
|
| 16 |
Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group
|
Lorusso, D.
|
|
|
21 |
1 |
p. 61-66
|
artikel
|
| 17 |
Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma
|
Lurje, G.
|
|
|
21 |
1 |
p. 78-86
|
artikel
|
| 18 |
Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical–translational research experience at the Catalan Institute of Oncology
|
Martin-Castillo, B.
|
|
|
21 |
1 |
p. 187-189
|
artikel
|
| 19 |
Influence of an independent review committee on assessment of response rate and progression-free survival in phase III clinical trials
|
Tang, P.A.
|
|
|
21 |
1 |
p. 19-26
|
artikel
|
| 20 |
Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy
|
Song, M.-K.
|
|
|
21 |
1 |
p. 140-144
|
artikel
|
| 21 |
instructions to authors
|
|
|
|
21 |
1 |
p. 191-194
|
artikel
|
| 22 |
Interviewing patients using interpreters in an oncology setting: initial evaluation of a communication skills module
|
Lubrano di Ciccone, B.
|
|
|
21 |
1 |
p. 27-32
|
artikel
|
| 23 |
in this issue
|
|
|
|
21 |
1 |
p. 1
|
artikel
|
| 24 |
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients
|
Santini, D.
|
|
|
21 |
1 |
p. 185-186
|
artikel
|
| 25 |
Nephrotic syndrome caused by the angiogenesis inhibitor sorafenib
|
Overkleeft, E.N.M.
|
|
|
21 |
1 |
p. 184-185
|
artikel
|
| 26 |
Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary
|
Uzan, C.
|
|
|
21 |
1 |
p. 55-60
|
artikel
|
| 27 |
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis
|
Ishigami, H.
|
|
|
21 |
1 |
p. 67-70
|
artikel
|
| 28 |
Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
|
Molife, L.R.
|
|
|
21 |
1 |
p. 109-113
|
artikel
|
| 29 |
Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy
|
Kanai, M.
|
|
|
21 |
1 |
p. 189-190
|
artikel
|
| 30 |
Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors
|
Oosting, S.F.
|
|
|
21 |
1 |
p. 104-108
|
artikel
|
| 31 |
Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes
|
Nösslinger, T.
|
|
|
21 |
1 |
p. 120-125
|
artikel
|
| 32 |
Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma
|
Schaffel, R.
|
|
|
21 |
1 |
p. 133-139
|
artikel
|
| 33 |
Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature
|
Saad, E.D.
|
|
|
21 |
1 |
p. 7-12
|
artikel
|
| 34 |
Race and ethnicity correlate with survival in patients with gastric adenocarcinoma
|
Kim, J.
|
|
|
21 |
1 |
p. 152-160
|
artikel
|
| 35 |
Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer
|
Mavroudis, D.
|
|
|
21 |
1 |
p. 48-54
|
artikel
|
| 36 |
Second primary colorectal cancers (SPCRCs): experiences from a large Australian Cancer Registry
|
Ringland, C.L.
|
|
|
21 |
1 |
p. 92-97
|
artikel
|
| 37 |
Table of Contents
|
|
|
|
21 |
1 |
p. viii-ix
|
artikel
|
| 38 |
The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment
|
Bueno-de-Mesquita, J.M.
|
|
|
21 |
1 |
p. 40-47
|
artikel
|
| 39 |
Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma
|
Avigdor, A.
|
|
|
21 |
1 |
p. 126-132
|
artikel
|
| 40 |
Why do residents choose the medical oncology specialty? Implications for future recruitment—results of the 2007 French Association of Residents in Oncology (AERIO) Survey
|
Loriot, Y.
|
|
|
21 |
1 |
p. 161-165
|
artikel
|
Tijdschrift beschrijving